{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:21Z","timestamp":1787020221195,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["238042"],"award-info":[{"award-number":["238042"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5596-2","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T13:00:48Z","timestamp":1557234048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The healthcare costs of treating human papillomavirus-related cancers in Norway"],"prefix":"10.1186","volume":"19","author":[{"given":"Hannah","family":"Hylin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Thrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kine","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar S.","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-5849","authenticated-orcid":false,"given":"Emily A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"issue":"Supplement 5","key":"5596_CR1","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","volume":"30","author":"D Forman","year":"2012","unstructured":"Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Supplement 5):F12\u201323.","journal-title":"Vaccine"},{"key":"5596_CR2","volume-title":"Cancer in Norway 2014 - Cancer incidence, mortality, survival and prevalence in Norway","author":"Cancer Registry of Norway","year":"2015","unstructured":"Cancer Registry of Norway. Cancer in Norway 2014 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2015."},{"issue":"9916","key":"5596_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJF, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"key":"5596_CR4","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/bjc.2012.94","volume":"106","author":"EA Burger","year":"2012","unstructured":"Burger EA, Ortendahl JD, Sy S, Kristiansen IS, Kim JJ. Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway. Br J Cancer. 2012;106:1571.","journal-title":"Br J Cancer"},{"key":"5596_CR5","unstructured":"The Norwegian Institute of Public Health: Vaksine mot humant papillomavirus (HPV) - Rapport fra arbeidsgruppe nedsatt av Nasjonalt folkehelseinstitutt for \u00e5 vurdere om HPV vaksine til gutter skal tilbys i program i Norge. In. Oslo, Norway: The Norwegian Institute of Public Health; 2016."},{"issue":"1","key":"5596_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4220\/Sykepleienf.2015.53414","volume":"10","author":"K Pedersen","year":"2015","unstructured":"Pedersen K, L\u00f8nnberg S, Skare GB, S\u00f8rbye SW, Burger E, Kristiansen IS. Kostnader ved masseunders\u00f8kelsen mot livmorhalskreft. Sykeplein Forskning. 2015;10(1):62\u201371.","journal-title":"Sykeplein Forskning"},{"issue":"3","key":"5596_CR7","doi-asserted-by":"publisher","first-page":"e89974","DOI":"10.1371\/journal.pone.0089974","volume":"9","author":"Emily A. Burger","year":"2014","unstructured":"Burger EA, Sy S, Nyg\u00e5rd M, Kristiansen IS, Kim JJ. Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys (technical appendix). PLoS One. 2014;9(3).","journal-title":"PLoS ONE"},{"key":"5596_CR8","unstructured":"Oslo Economics. [Cancer in Norway- Patient costs, health services and society] Oslo, Norway; 2016."},{"issue":"1","key":"5596_CR9","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1186\/1471-2458-12-1082","volume":"12","author":"J Olsen","year":"2012","unstructured":"Olsen J, J\u00f8rgensen TR, Kofoed K, Larsen HK. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark. BMC Public Health. 2012;12(1):1082.","journal-title":"BMC Public Health"},{"issue":"6","key":"5596_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179520","volume":"12","author":"E \u00d6stensson","year":"2017","unstructured":"\u00d6stensson E, Silfverschi\u00f6ld M, Greiff L, Asciutto C, Wennerberg J, Lydryp M-L, H\u00e5kansson U, Spar\u00e9n P, Borgfeldt C. The economic burden of human papillomavirus-related precancers and cancers in Sweden. PLoS One. 2017;12(6):e0179520.","journal-title":"PLoS One"},{"key":"5596_CR11","volume-title":"Cost effectiveness in health and medicine","author":"PJ Neumann","year":"2017","unstructured":"Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost effectiveness in health and medicine. 2nd ed. New York: Oxford University Press; 2017.","edition":"2"},{"key":"5596_CR12","unstructured":"DNB. [Average Exchange Rates] 2014 [\n                    https:\/\/www.dnb.no\/bedrift\/markets\/valuta-renter\/valutakurser-og-renter\/historiske\/hovedvalutaer\/2014.html\n                    \n                  ]. [Accessed 19 Sept 2018]."},{"key":"5596_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.vhri.2018.06.001","volume":"17","author":"RJV Alves","year":"2018","unstructured":"Alves RJV, Etges A, Neto GB, Polanczyk CA. Activity-based costing and time-driven activity-based costing for assessing the costs of Cancer prevention, diagnosis, and treatment: a systematic review of the literature. Value Health Reg Issues. 2018;17:142\u20137.","journal-title":"Value Health Reg Issues"},{"key":"5596_CR14","unstructured":"[Regulations for coverage of expenses for physicians] Oslo, Norway; 2015 [\n                    https:\/\/lovdata.no\/dokument\/LTI\/forskrift\/2015-06-26-796\n                    \n                  ]. [Accessed 15 Mar 2017]."},{"key":"5596_CR15","unstructured":"Hansen B, Campbell S, Nyg\u00e5rd M: HPV-relatert kreft i Norge. Cancer in Norway 2014 - Special issue 2015."},{"issue":"6","key":"5596_CR16","doi-asserted-by":"publisher","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","volume":"107","author":"M Saraiya","year":"2015","unstructured":"Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107(6):djv086.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"5596_CR17","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1001\/archinte.1996.00440180055007","volume":"156","author":"AP Legorreta","year":"1996","unstructured":"Legorreta AP, Brooks RJ, Leibowitz AN, Solin LJ. Cost of breast cancer treatment: a 4-year longitudinal study. Arch Intern Med. 1996;156(19):2197\u2013201.","journal-title":"Arch Intern Med"},{"issue":"6","key":"5596_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jnci\/87.6.417","volume":"87","author":"SH Taplin","year":"1995","unstructured":"Taplin SH, Barlow W, Urban N, Mandelson MT, Timlin DJ, Ichikawa L, Nefcy P. Stage, age, comorbidity, and direct costs of Colon, prostate, and breast Cancer care. J Natl Cancer Inst. 1995;87(6):417\u201326.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5596_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jnci\/djq495","volume":"103","author":"AB Mariotto","year":"2011","unstructured":"Mariotto AB, Robin Yabroff K, Shao Y, Feuer EJ, Brown ML. Projections of the cost of Cancer Care in the United States: 2010\u20132020. J Natl Cancer Inst. 2011;103(2):117\u201328.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5596_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1200\/JCO.2002.20.1.307","volume":"20","author":"JL Warren","year":"2002","unstructured":"Warren JL, Brown ML, Fay MP, Schussler N, Potosky AL, Riley GF. Costs of treatment for elderly women with early-stage breast Cancer in fee-for-service settings. J Clin Oncol. 2002;20(1):307\u201316.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5596_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/0284186X.2014.948061","volume":"54","author":"M Anshushaug","year":"2015","unstructured":"Anshushaug M, Gynnild MA, Kaasa S, Kvikstad A, Gr\u00f8nberg BH. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncol. 2015;54(3):395\u2013402.","journal-title":"Acta Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5596-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5596-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5596-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T19:11:46Z","timestamp":1588705906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5596-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5596"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5596-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NPR, KUHR and NorPD were analyzed with anonymized patient IDs, and were not linked. The study was approved by the Norwegian Center for Research Data (project reference 52580).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No details on individuals are reported within the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"426"}}